Skip to main content
Biohit Oyj logo

Biohit Oyj — Investor Relations & Filings

Ticker · BIOBV ISIN · FI0009005482 LEI · 74370089ATTSNBXJVT29 HE Manufacturing
Filings indexed 992 across all filing types
Latest filing 2023-03-22 Annual Report
Country FI Finland
Listing HE BIOBV

Biohit Oyj is a global biotechnology company that develops, manufactures, and markets innovative diagnostic products and services. The company specializes in tools for the early diagnosis and prevention of diseases, with a primary focus on gastroenterology. Its key offerings include the GastroPanel® blood test for assessing stomach health and screening for risks of gastric cancer, as well as diagnostic tests for conditions such as Helicobacter pylori infection. Operating under the mission "Innovating for Health," Biohit's products are designed to support medical research, facilitate early and accurate diagnosis, and improve patient quality of life.

Recent filings

Filing Released Lang Actions
74370089ATTSNBXJVT29-2022-12-31-fi.zip
Annual Report Classification · 100% confidence The document is titled 'VUOSIKERTOMUS 2022' which translates to 'Annual Report 2022' in Finnish. It contains detailed sections typical of an annual report such as CEO review, strategy, governance, and financial statements. It includes comprehensive financial data for the year 2022, management discussion, and governance information. The length is substantial (15,000 characters), indicating it is the full report rather than an announcement or summary. There is no indication that this is a transcript, a regulatory filing, or a presentation. Therefore, this document fits the definition of an Annual Report (10-K). FY 2022
2023-03-22 Finnish
Biohit Oyj:n vuosikertomus 2022 on julkaistu
Report Publication Announcement Classification · 100% confidence The document is a short announcement (under 2,500 characters) stating that the company's 2022 Annual Report has been published and provides a link to the company's website to download it. Per the 'Menu vs Meal' rule, this is an announcement of a report, not the report itself, and therefore qualifies as a Report Publication Announcement (RPA).
2023-03-22 Finnish
Biohit Oyj Vuosikertomus 2022_FI.pdf
Annual Report Classification · 100% confidence The document is titled 'VUOSIKERTOMUS 2022' (Annual Report 2022) for BIOHIT HealthCare. It contains comprehensive sections including the CEO's review, strategy, governance, and audited financial statements (Tilinpäätös). It is a full-length annual report covering the fiscal year 2022, not an announcement or a summary. FY 2022
2023-03-22 Finnish
03215981.pdf
Report Publication Announcement Classification · 100% confidence The document is a short announcement (approx. 1172 characters) stating that the 2022 Annual Report has been published and provides a link to the company's website to download it. Per the 'Menu vs Meal' rule, this is an announcement of a report, not the report itself, and therefore qualifies as a Report Publication Announcement (RPA).
2023-03-22 Finnish
Biohit Oyj:n vuosikertomus 2022 on julkaistu
Report Publication Announcement Classification · 100% confidence The document is a short announcement (1461 characters) stating that the 2022 Annual Report has been published and provides a link to the company's website to download it. Per the 'Menu vs Meal' rule, since this is an announcement of a report rather than the report itself, it is classified as a Report Publication Announcement (RPA).
2023-03-22 Finnish
03215982.pdf
Report Publication Announcement Classification · 100% confidence The document is a short announcement (approx. 1100 characters) stating that the 'Annual Report 2022' has been published and provides a link to the company website to download it. Per the 'Menu vs Meal' rule, this is an announcement of a report, not the report itself, and therefore qualifies as a Report Publication Announcement (RPA).
2023-03-22 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.